BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20493693)

  • 21. The nuclear pore component Nup358 promotes transportin-dependent nuclear import.
    Hutten S; Wälde S; Spillner C; Hauber J; Kehlenbach RH
    J Cell Sci; 2009 Apr; 122(Pt 8):1100-10. PubMed ID: 19299463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional rescue of an oligomerization-defective HIV-1 Rev mutant by fusion with an oligomeric tag.
    Furnes C; Andresen V; Szilvay AM
    Arch Virol; 2008; 153(2):357-62. PubMed ID: 18094922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Titration of cellular export factors, but not heteromultimerization, is the molecular mechanism of trans-dominant HTLV-1 rex mutants.
    Heger P; Rosorius O; Hauber J; Stauber RH
    Oncogene; 1999 Jul; 18(28):4080-90. PubMed ID: 10435589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.
    Wodrich H; Bohne J; Gumz E; Welker R; Kräusslich HG
    J Virol; 2001 Nov; 75(22):10670-82. PubMed ID: 11602709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
    Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
    Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function.
    González-Bulnes L; Ibáñez I; Bedoya LM; Beltrán M; Catalán S; Alcamí J; Fustero S; Gallego J
    Angew Chem Int Ed Engl; 2013 Dec; 52(50):13405-9. PubMed ID: 24214163
    [No Abstract]   [Full Text] [Related]  

  • 28. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins.
    Kubota S; Pomerantz RJ
    Oncogene; 1998 Apr; 16(14):1851-61. PubMed ID: 9583682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope.
    Zhuang X; Stahl SJ; Watts NR; DiMattia MA; Steven AC; Wingfield PT
    J Biol Chem; 2014 Jul; 289(29):20222-33. PubMed ID: 24878961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of beta-hairpin peptidomimetics that inhibit binding of alpha-helical HIV-1 Rev protein to the rev response element RNA.
    Moehle K; Athanassiou Z; Patora K; Davidson A; Varani G; Robinson JA
    Angew Chem Int Ed Engl; 2007; 46(47):9101-4. PubMed ID: 17893894
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunotherapeutic properties of medicinal plants. II. Plant immunomodulator macromolecules].
    Stănescu U; Grigorescu E
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(4):731-9. PubMed ID: 3330847
    [No Abstract]   [Full Text] [Related]  

  • 33. [Screening test for calcium antagonists in natural products and the active principles of Cnidii monnieri].
    Yamahara J; Miki S; Murakami H; Sawada T; Fujimura H
    Yakugaku Zasshi; 1985 May; 105(5):449-58. PubMed ID: 4032234
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic overlap for ten cardiovascular diseases: A comprehensive gene-centric pleiotropic association analysis and Mendelian randomization study.
    Liu Z; Xu J; Tan J; Li X; Zhang F; Ouyang W; Wang S; Huang Y; Li S; Pan X
    iScience; 2023 Nov; 26(11):108150. PubMed ID: 37908310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary Study on Antifungal Mechanism of Aqueous Extract of
    Yanyun C; Ying T; Wei K; Hua F; Haijun Z; Ping Z; Shunming X; Jian W
    Front Microbiol; 2021; 12():707174. PubMed ID: 34489895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytochemistry, Ethnopharmacology, Pharmacokinetics and Toxicology of
    Sun Y; Yang AWH; Lenon GB
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028721
    [No Abstract]   [Full Text] [Related]  

  • 37. CRM1 Inhibitors for Antiviral Therapy.
    Mathew C; Ghildyal R
    Front Microbiol; 2017; 8():1171. PubMed ID: 28702009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.
    Zhang ZR; Leung WN; Cheung HY; Chan CW
    Evid Based Complement Alternat Med; 2015; 2015():919616. PubMed ID: 26246843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
    Tamura S; Fujitani T; Kaneko M; Murakami N
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3717-20. PubMed ID: 20493693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Rev-export inhibitor from Alpinia galanga and structure-activity relationship.
    Tamura S; Shiomi A; Kaneko M; Ye Y; Yoshida M; Yoshikawa M; Kimura T; Kobayashi M; Murakami N
    Bioorg Med Chem Lett; 2009 May; 19(9):2555-7. PubMed ID: 19342232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.